Trials / Completed
CompletedNCT07519785
Prognostic Value of PLR On Cardiovascular Complications in Chronic Hemodialysis Patients
Prognostic Value of the Platelet to Lymphocyte Ratio on Cardiovascular Complications in Chronic Hemodialysis Patients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 80 (actual)
- Sponsor
- Minia University · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
Prognostic value of platelet to lymphocyte ratio on cardiovascular complications in chronic hemodialysis patients this study was done to determine the prognostic value of PLR on cardiovascular complications like vascular calcifications and atherosclerosis in carotid and coronary arteries in chronic hemodialysis patients
Detailed description
Prognostic value of platelet to lymphocyte ratio on cardiovascular complications in chronic hemodialysis patients this study was done to determine the prognostic value of PLR on cardiovascular complications like vascular calcifications and atherosclerosis in carotid and coronary arteries as these complications are common and well-known causes of morbidity and mortality in chronic hemodialysis patients
Conditions
Timeline
- Start date
- 2024-01-04
- Primary completion
- 2024-06-04
- Completion
- 2024-08-04
- First posted
- 2026-04-09
- Last updated
- 2026-04-13
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT07519785. Inclusion in this directory is not an endorsement.